Abstract. Pharmacy benefit managers dominate the U.S. pharmaceutical market but are controversial and poorly understood. We analyze PBMs as market

(Forthcoming Article) - In a model of moral hazard in teams, we demonstrate that firms’ concerns about low trust among teammates can justify two common but otherwise puzzling patterns: information was...